Total Credits: 1 including 1 AOA Category 1-A Credit(s)
First presented at the OPSO Annual Primary Care CME Conference on September 27, 2019. Join us for this on-demand CME presentation where William Elliott, MD provides his insightful (and always entertaining) review of US Hypertnesion Guidelines.
Educational Objectives:
At the end of this presentation, the awake audience members should be able to:
1. Name at least one advantage and at least one disadvantage for the most current US hypertension guidelins(s) promulgated by:
a. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7),
b. The panel members appointed to JNC 8,
c. The American Society of Hypertension and the International Society of Hypertension,
d. The American Diabetes Association,
e. The National Kidney Foundation, and
f. The American College of Cardiology and The American Heart Association.
Dr. Elliott discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of his presentation.
The Osteopathic Physicians and Surgeons of Oregon is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
Grievance Policy:
All grievances may be directed to OPSO Executive Director at info@opso.org. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
William J. Elliott, M.D., Ph.D. is Professor of Preventive Medicine, Internal Medicine, and Pharmacology, Chief of the Division of Pharmacology, and Chair of The Department of Biomedical Sciences at the Pacific Northwest University of Health Sciences in Yakima, WA. After receiving the B.S. (summa cum laude) from the University of Notre Dame, he earned the M.D. and Ph.D. (in Bio-Organic Chemistry) from the University of Chicago. He trained in Internal Medicine and Pharmacology at Barnes Hospital and Washington University—St. Louis, and served as a member of the faculty of the University of Chicago from 1985-92. During the next 17 years at RUSH Medical College, he practiced, taught and did research on cardiovascular clinical pharmacology, focusing on epidemiologic studies of risk factors (including diagonal earlobe creases), laboratory investigations, federally-funded cooperative clinical trials, and many industry-supported endeavors, serving as principal investigator for about 200 clinical trials of new drugs. Dr. Elliott holds Board Certification in both Internal Medicine and Clinical Pharmacology. One of the inaugural “Specialists in Clinical Hypertension” and Fellows of the American Society of Hypertension, he contributed on five topics to JNC VI, as well as to the “long version” of JNC 7. Some of his recent publications include meta-analyses of clinical trial results, putative risk factors for cardiovascular disease, cost-containment, pharmacoeconomics, and the assessment and enhancement of medication adherence. Dr. Elliott belongs to many professional societies interested in clinical pharmacology and in hypertension, including fellowship in the American Heart Association’s High Blood Pressure Council. He has lectured on five continents, participated in the review process for many journals, societies, study sections, and funding agencies, and served as editor or co-editor for many books, monographs, and symposia. Among his honors are 29 awards for teaching excellence.
Dr. William Elliott discloses that he has author and editor relationships with Elsevier and Wolters Kluwer for which he received royalties. He discloses that he has no other relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of his presentation.
|
Linking Pain, Trauma, and Substance Abuse, A Behavioral Health Primer
Original Program Date: 09/26/2019 |
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|